Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.
Boden H, Ahmed TA, Velders MA, van der Hoeven BL, Hoogslag GE, Bootsma M, le Cessie S, Cobbaert CM, Delgado V, van der Laarse A, Schalij MJ. Boden H, et al. Am J Cardiol. 2013 May 15;111(10):1387-93. doi: 10.1016/j.amjcard.2013.01.284. Epub 2013 Apr 24. Am J Cardiol. 2013. PMID: 23465094 Clinical Trial.
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
Boden H, van der Hoeven BL, Liem SS, Atary JZ, Cannegieter SC, Atsma DE, Bootsma M, Jukema JW, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ. Boden H, et al. EuroIntervention. 2012 Jan;7(9):1021-9. doi: 10.4244/EIJV7I9A164. EuroIntervention. 2012. PMID: 22207227 Free article. Clinical Trial.
Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
Antoni ML, Hoogslag GE, Boden H, Liem SS, Boersma E, Fox K, Schalij MJ, Bax JJ, Delgado V. Antoni ML, et al. Among authors: boden h. Am J Cardiol. 2012 Jan 15;109(2):187-94. doi: 10.1016/j.amjcard.2011.08.029. Am J Cardiol. 2012. PMID: 22244127
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.
Rodrigo SF, van Ramshorst J, Hoogslag GE, Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I, Dibbets-Schneider P, Fibbe WE, Zwaginga JJ, Bax JJ, Schalij MJ, Beeres SL, Atsma DE. Rodrigo SF, et al. Among authors: boden h. J Cardiovasc Transl Res. 2013 Oct;6(5):816-25. doi: 10.1007/s12265-013-9507-7. Epub 2013 Aug 28. J Cardiovasc Transl Res. 2013. PMID: 23982478 Free PMC article. Clinical Trial.
57 results